| AL Amyloidosis studied in …STUDIED_INderived79 of 79show fewer |
|---|
| → studied in | NCT06768489Phase 1 · recruiting A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma · condition mapped ALIAS · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07172243recruiting BE.Amycon Biobank & Data Registry UZ Leuven · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07215494NA · recruiting A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis · condition mapped ALIAS · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07103863enrolling by invitation Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07615270early Phase 1 · not yet recruiting A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05145816Phase 1/Phase 2 · recruiting Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06569147Phase 1/Phase 2 · recruiting Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07751471Phase 2 · not yet recruiting BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004) · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05184088Phase 3 · completed Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07638683Phase 2 · recruiting A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL). · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04617925Phase 2 · completed A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04847453Phase 1 · active not recruiting Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis · condition mapped CURATED_BROADER · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07335887Phase 2 · recruiting Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06649695Phase 2 · active not recruiting A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06855121recruiting The Norwegian Immunotherapy in Multiple Myeloma Study · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04754945Phase 1 · active not recruiting Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06097832Phase 1/Phase 2 · active not recruiting Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis · condition mapped ALIAS · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05451771Phase 1/Phase 2 · active not recruiting Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07689331recruiting Hungarian National Systemic Amyloidosis Registry · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06192979NA · recruiting Optimize First-line Treatment for AL Amyloidosis With t (11; 14) · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04504825Phase 3 · active not recruiting A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES) · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07081646Phase 1/Phase 2 · recruiting A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis. · condition mapped CURATED_BROADER · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06971848NA · recruiting Evaluation of Skin Tests in Biotherapy Allergies · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04512235Phase 3 · active not recruiting A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES) · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07626476early Phase 1 · recruiting Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07624760NA · not yet recruiting Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07585331completed Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06022939Phase 3 · recruiting Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07448935recruiting One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06769555NA · withdrawn BCMA/CD3 BiTE for RRAL or NDAL Amyloidosis With Insufficient Depth of Hematologic Response After Induction Therapy · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04392960NA · completed Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04839003recruiting A Registry of AL Amyloidosis (ReAL) · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06205953recruiting A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA) · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06383143recruiting Promoting Diagnosis and Management of AL in Italy (ProDigALIty) · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05898646Phase 2 · recruiting Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01408225recruiting Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03431896completed Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01758042NA · completed Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07448779recruiting Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04270175Phase 2 · active not recruiting Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03618537Phase 2 · active not recruiting Ixazomib Maintenance Study in Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03315026Phase 2 · active not recruiting Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07085559early Phase 1 · recruiting Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07079423Phase 2 · recruiting Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07055724Phase 2 · not yet recruiting Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06935162Phase 2 · recruiting Teclistamab in Previously Treated AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06699394NA · recruiting Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05486481Phase 1/Phase 2 · withdrawn Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE) · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04304144Phase 2 · completed A Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04895917Phase 2 · terminated Daratumumab and Pomalidomide in Previously Treated Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02245867Phase 1 · completed Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05199337Phase 1/Phase 2 · completed Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04659798completed A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice · condition mapped ALIAS · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06376214NA · recruiting Daratumumab for Patients With Light Chain Amyloidosis · condition mapped ALIAS · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05066607Phase 2 · unknown Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04210791enrolling by invitation Autologous Stem Cell Transplantation for Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06186167unknown Amyloidosis Incidence in High-Risk Cardiac Device Patients · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05028374Phase 2 · completed COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06065852recruiting National Registry of Rare Kidney Diseases · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05776940Phase 3 · unknown Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis · condition mapped ALIAS · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04984330early Phase 1 · withdrawn Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03236792Phase 1/Phase 2 · completed Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04937777completed A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05277493unknown A Registry of Chinese AL Amyloidosis Patients Treated With Subcutaneous or Intravenous Daratumumab · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04115956Phase 1 · terminated A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02841033Phase 1/Phase 2 · completed Daratumumab for the Treatment of Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04612582Phase 4 · unknown Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis · condition mapped ALIAS · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01570387Phase 1/Phase 2 · completed A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03000660Phase 1 · terminated Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01222260Phase 2 · completed Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02613182Phase 2 · terminated Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02574676completed Quality of Life (QOL) Registry for Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02632786Phase 2 · completed The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03154047Phase 2 · terminated Study in Subjects With Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02489500Phase 3 · terminated Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01277016Phase 3 · completed A Trial for Systemic Light-chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02257905completed Allo SCT in Amyloidosis Non-interventional Study · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01815086Phase 1 · completed Radioimmunoimaging of Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01409148Phase 1 · completed Radioimmunoimaging of AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 79 trials mapped (43 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |